Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive blood pressure registry aims to personalize care

NCT ID NCT04160533

Knowledge-focused Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a registry of over 10,000 people with high blood pressure. Researchers will collect data on their health, treatments, and outcomes to find patterns and improve care. The goal is to help doctors provide more personalized and effective treatment based on real-world evidence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2018

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

outpatient patients from 18 to 99 years old with a diagnosis of hypertension

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The diagnosis of arterial hypertension - Exclusion Criteria: No diagnosis of arterial hypertension \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    17 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation

    RECRUITING

    Moscow, Moscow Oblast, 121552, Russia

  • Municipal Health Institution "City Hospital No. 1" Volgodonsk

    RECRUITING

    Volgodonsk, Russia

  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №1

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №2

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №3

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №4

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №1

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №4

    RECRUITING

    Taganrog, Russia

  • Municipal budgetary institution of public health services "City ambulance hospital" city of Taganrog

    RECRUITING

    Taganrog, Russia

  • Municipal health institution "City polyclinic №1" Volgodonsk

    RECRUITING

    Volgodonsk, Russia

  • Municipal health institution "City polyclinic №3" Volgodonsk

    RECRUITING

    Volgodonsk, Russia

  • State Autonomous Healthcare Institution of the Tyumen Region "Tyumen Institute of Therapy

    RECRUITING

    Tyumen, Russia

  • State Healthcare Institution "Engels City Polyclinic No. 2

    RECRUITING

    Engel's, Russia

  • State Healthcare Institution "Engels City Polyclinic No. 4

    RECRUITING

    Engel's, Russia

  • State budgetary health institution of the Kemerovo region "Kemerovo Regional Clinical Cardiology Dispensary named after Academician L.S. Barbarash

    RECRUITING

    Kemerovo, Russia

  • State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic

    RECRUITING

    Volgograd, Russia

  • State budgetary institution of the ryazan region "regional clinical cardiological dispensary"

    RECRUITING

    Ryazan, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.